搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Trimeresurus gramineus Snake venom serine protease 1 (TLG1) CSB-YP519258TQK
CSB-EP519258TQK
CSB-BP519258TQK
CSB-MP519258TQK
CSB-EP519258TQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Matrix metalloproteinase-18 (mmp18) CSB-YP519259XBE
CSB-EP519259XBE
CSB-BP519259XBE
CSB-MP519259XBE
CSB-EP519259XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Protein groucho-2 (gro2), partial CSB-YP519260DIL
CSB-EP519260DIL
CSB-BP519260DIL
CSB-MP519260DIL
CSB-EP519260DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tiggy-winkle hedgehog protein (twhh) CSB-YP519261FGX
CSB-EP519261FGX
CSB-BP519261FGX
CSB-MP519261FGX
CSB-EP519261FGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Liza aurata Metallothionein (mt) CSB-YP519262LQE
CSB-EP519262LQE
CSB-BP519262LQE
CSB-MP519262LQE
CSB-EP519262LQE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida tropicalis Isocitrate dehydrogenase [NADP], mitochondrial (IDP1) CSB-YP519263CZN
CSB-EP519263CZN
CSB-BP519263CZN
CSB-MP519263CZN
CSB-EP519263CZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Histone deacetylase phd1 (phd1) CSB-YP519264SXV
CSB-EP519264SXV
CSB-BP519264SXV
CSB-MP519264SXV
CSB-EP519264SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnaporthe oryzae Guanine nucleotide-binding protein subunit alpha (MAGB) CSB-YP519265MPM
CSB-EP519265MPM
CSB-BP519265MPM
CSB-MP519265MPM
CSB-EP519265MPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Ubiquitin-like protein pmt3/smt3 (pmt3) CSB-YP519266SXV
CSB-EP519266SXV
CSB-BP519266SXV
CSB-MP519266SXV
CSB-EP519266SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kluyveromyces lactis Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDA1), partial CSB-YP519267KBK
CSB-EP519267KBK
CSB-BP519267KBK
CSB-MP519267KBK
CSB-EP519267KBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Orotidine 5'-phosphate decarboxylase (pyrG) CSB-YP519268NGS
CSB-EP519268NGS
CSB-BP519268NGS
CSB-MP519268NGS
CSB-EP519268NGS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida boidinii Formate dehydrogenase (FDH1) CSB-YP519269CZG
CSB-EP519269CZG
CSB-BP519269CZG
CSB-MP519269CZG
CSB-EP519269CZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptococcus neoformans var. grubii Urease (URE1), partial CSB-YP519270DYM
CSB-EP519270DYM
CSB-BP519270DYM
CSB-MP519270DYM
CSB-EP519270DYM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Myb-like DNA-binding protein myb-1 (rca-1) CSB-YP519271NHA
CSB-EP519271NHA
CSB-BP519271NHA
CSB-MP519271NHA
CSB-EP519271NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae 40S ribosomal protein S9-A (RPS9A) CSB-YP519272SVG
CSB-EP519272SVG
CSB-BP519272SVG
CSB-MP519272SVG
CSB-EP519272SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YDR396W (YDR396W), partial CSB-YP519273SVG1
CSB-EP519273SVG1
CSB-BP519273SVG1
CSB-MP519273SVG1
CSB-EP519273SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YLR202C (YLR202C) CSB-YP519274SVG
CSB-EP519274SVG
CSB-BP519274SVG
CSB-MP519274SVG
CSB-EP519274SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YHR139C-A (YHR139C-A) CSB-YP519275SVG
CSB-EP519275SVG
CSB-BP519275SVG
CSB-MP519275SVG
CSB-EP519275SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YLR282C (YLR282C) CSB-YP519276SVG
CSB-EP519276SVG
CSB-BP519276SVG
CSB-MP519276SVG
CSB-EP519276SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YPR099C (YPR099C) CSB-YP519277SVG
CSB-EP519277SVG
CSB-BP519277SVG
CSB-MP519277SVG
CSB-EP519277SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>